{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T00:27:56Z","timestamp":1791073676663,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"36","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1016\/j.vaccine.2010.06.062","type":"journal-article","created":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T04:38:09Z","timestamp":1277959089000},"page":"5850-5856","source":"Crossref","is-referenced-by-count":91,"title":["Safety and efficacy of novel dermal and epidermal microneedle delivery systems for rabies vaccination in healthy adults"],"prefix":"10.1016","volume":"28","author":[{"given":"Philippe E.","family":"Laurent","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herv\u00e9","family":"Bourhy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Fantino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Alchas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Mikszta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2010.06.062_bib1","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1586\/14760584.7.8.1201","article-title":"Intradermal, epidermal and transcutaneous vaccination: from immunology to clinical practice","volume":"7","author":"Nicolas","year":"2008","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2010.06.062_bib2","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1016\/j.vaccine.2008.03.095","article-title":"Intradermal vaccine delivery: will new delivery systems transform vaccine administration?","volume":"26","author":"Lambert","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.06.062_bib3","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1056\/NEJMe048314","article-title":"Intradermal influenza vaccination\u2014can less be more?","volume":"351","author":"La Montagne","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2010.06.062_bib4","series-title":"Options for the CONTROL of influenza VI","article-title":"Immunogenicity of a novel influenza vaccine delivered by intradermal microinjection in over 60 year-olds","author":"Booy","year":"2007"},{"key":"10.1016\/j.vaccine.2010.06.062_bib5","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1086\/590434","article-title":"Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: a randomized controlled trial","volume":"198","author":"Holland","year":"2008","journal-title":"J Infect Dis"},{"issue":"278","key":"10.1016\/j.vaccine.2010.06.062_bib6","first-page":"88","article-title":"Protective immunization against inhalation ianthrax: a comparison of minimally invasive delivery platform","volume":"191","author":"Mikszta","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2010.06.062_bib7","doi-asserted-by":"crossref","first-page":"106","DOI":"10.4161\/hv.1.3.1797","article-title":"Cutaneous delivery of a live, attenuated chimeric flavivirus vaccine against Japanese encephalitis (ChimeriVax)-JE) in non-human primates","volume":"1","author":"Dean","year":"2005","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.vaccine.2010.06.062_bib8","doi-asserted-by":"crossref","first-page":"6806","DOI":"10.1128\/IAI.01210-06","article-title":"Microneedle-based intradermal delivery of the anthrax recombinant protective antigen vaccine","volume":"74 (December)","author":"Mikszta","year":"2006","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2010.06.062_bib9","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1128\/CVI.00387-06","article-title":"Preclinical evaluation of microneedle technology for intradermal delivery of influenza vaccines","volume":"14","author":"Alarcon","year":"2007","journal-title":"Clin Vaccine Immunol: CVI"},{"key":"10.1016\/j.vaccine.2010.06.062_bib10","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1476-8518-6-5","article-title":"An alternative approach to combination vaccines: intradermal administration of isolated components for control of anthrax, botulism, plague and staphylococcal toxic shock","volume":"6","author":"Morefield","year":"2008","journal-title":"J Immune Based Thera Vaccine"},{"key":"10.1016\/j.vaccine.2010.06.062_bib11","doi-asserted-by":"crossref","first-page":"8833","DOI":"10.1016\/j.vaccine.2007.10.020","article-title":"Evaluation of the clinical performance of a new intradermal vaccine administration technique and associated delivery system","volume":"25","author":"Laurent","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.06.062_bib12","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/S0264-410X(98)00045-0","article-title":"Safety and efficacy of purified Vero cell rabies vaccine given intramuscularly and intradermally. (Results of a prospective randomized trial)","volume":"16","author":"Jaiiaroensup","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.06.062_bib13","first-page":"896","article-title":"Economical multiple-site intradermal immunization with human diploid-cell-strain vaccine is effective for post-exposure rabies prophylaxis","volume":"335","author":"Warrel","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2010.06.062_bib14","series-title":"Recommendations on rabies postexposure treatment and the correct technique of intradermal immunization against rabies. WHO\/EMC.ZOO 96.6","author":"WHO","year":"1996"},{"key":"10.1016\/j.vaccine.2010.06.062_bib15","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nm0402-415","article-title":"Improved genetic immunization via micromechanical disruption of skin barrier function and targeted epidermal delivery","volume":"8","author":"Mikszta","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2010.06.062_bib16","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.it.2006.01.003","article-title":"Langerhans cells\u2014revisiting the paradigm using genetically engineered mice","volume":"27","author":"Kissenpfennig","year":"2006","journal-title":"Trends Immunol"},{"issue":"49\u201350","key":"10.1016\/j.vaccine.2010.06.062_bib17","first-page":"425","article-title":"Rabies vaccines. WHO position paper","volume":"82","author":"WHO","year":"2007","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2010.06.062_bib18","unstructured":"Intradermal delivery of vaccines, WHO-PATH, 2009."},{"key":"10.1016\/j.vaccine.2010.06.062_bib19","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1592\/phco.29.10.1182","article-title":"Overview, prevention, and treatment of rabies","volume":"29","author":"Nigg","year":"2009","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.vaccine.2010.06.062_bib20","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1016\/j.vaccine.2010.03.039","article-title":"The immune response to rabies virus and vaccination","volume":"28","author":"Johnson","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.06.062_bib21","unstructured":"WHO Report: Intradermal application of rabies vaccines, Bangkok, Thailand, 5\u20136 June 2000? WHO\/CDS\/CSR\/APH\/2000.5."},{"key":"10.1016\/j.vaccine.2010.06.062_bib22","series-title":"WHO expert consultation on rabies, First Report, WHO Technical Report Series 931","author":"WHO","year":"2005"},{"key":"10.1016\/j.vaccine.2010.06.062_bib23","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1001\/jama.247.8.1138","article-title":"Human diploid cell rabies vaccine. Effectiveness of immunization with small intradermal or subcutaneous doses","volume":"247","author":"Bernard","year":"1982","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2010.06.062_bib24","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S0140-6736(75)91761-4","article-title":"Immunogenicity and acceptability of human diploid cell culture rabies vaccine in volunteers","volume":"22","author":"Aoki","year":"1975","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2010.06.062_bib25","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/S0140-6736(76)93028-2","article-title":"Human diploid cell strain rabies vaccine. Rapid prophylactic immunization of volunteers with small doses","volume":"1","author":"Turner","year":"1976","journal-title":"Lancet"},{"issue":"8252","key":"10.1016\/j.vaccine.2010.06.062_bib26","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S0140-6736(81)91402-1","article-title":"Multisite intradermal antirabies vaccination. Immune responses in man and protection of rabbits against death from street virus by postexposure administration of human diploid-cell-strain rabies vaccine","volume":"2","author":"Nicholson","year":"1981","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2010.06.062_bib27","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1016\/j.vaccine.2008.04.081","article-title":"Intradermal pre-exposure rabies vaccine elicits long lasting immunity","volume":"26","author":"Brown","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.06.062_bib28","first-page":"491","article-title":"An effective economical intradermal regimen of human diploid cell rabies vaccination for post-exposure treatment","volume":"63","author":"Ubol","year":"1986","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.vaccine.2010.06.062_bib29","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0001-706X(99)00092-3","article-title":"Immunogenicity and effectiveness of post-exposure rabies prophylaxis with a new chromatographically purified Vero-cell rabies vaccine (CPRV): a two-stage randomised clinical trial in the Philippines","volume":"75","author":"Quiambao","year":"2000","journal-title":"Acta Trop"},{"issue":"8694","key":"10.1016\/j.vaccine.2010.06.062_bib30","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/0140-6736(90)90488-Q","article-title":"Postexposure prophylaxis for rabies with antiserum and intradermal vaccination","volume":"335","author":"Chutivongse","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2010.06.062_bib31","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.1016\/S0264-410X(01)00238-9","article-title":"Immunogenicity, safety and lot consistency in adults of a chromatographically purified Vero-cell rabies vaccine: a randomized, double-blind trial with human diploid cell rabies vaccine","volume":"19","author":"Jones","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.06.062_bib32","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1016\/j.vaccine.2005.03.007","article-title":"Potency requirements of rabies vaccines administered intradermally using the Thai Red Cross regimen: investigation of the immunogenicity of serially diluted purified chick embryo cell rabies vaccine","volume":"23","author":"Beran","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.06.062_bib33","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.vaccine.2004.08.001","article-title":"An immunogenicity study of a newly introduced purified Vero cell rabies vaccine (Abhayrab) manufactured in India","volume":"23","author":"Sampath","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.06.062_bib34","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1001\/jama.277.21.1709","article-title":"Determination of deltoid fat pad thickness: implications for needle length in adult immunization","volume":"277","author":"Poland","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2010.06.062_bib35","unstructured":"Bourhy H, Sureau P. Methodes de laboratoire pour le diagnostic de la rage. Metodos de laboratorio para el diagnostico de la rabia. Laboratory methods for rabies diagnosis. Ed by Commission des Laboratoires de R\u00e9f\u00e9rence et d\u2019Expertise de l\u2019Institut Pasteur; 1991. p. 197."},{"key":"10.1016\/j.vaccine.2010.06.062_bib36","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0022-3565(25)08751-8","article-title":"Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes","volume":"82","author":"Draize","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.vaccine.2010.06.062_bib37","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0304-3959(97)00005-5","article-title":"The visual analogue scale pain intensity scale: what is moderate pain in millimeters?","volume":"72","author":"Collins","year":"1997","journal-title":"Pain"},{"key":"10.1016\/j.vaccine.2010.06.062_bib38","series-title":"Design and analysis of experiments","author":"Montgomery","year":"1991"},{"key":"10.1016\/j.vaccine.2010.06.062_bib39","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jconrel.2005.02.002","article-title":"Biodegradable polymer microneedles: fabrication, mechanics and transdermal drug delivery","volume":"104","author":"Park","year":"2005","journal-title":"J Control Release"},{"key":"10.1016\/j.vaccine.2010.06.062_bib40","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1749-6632.2009.04083.x","article-title":"Optimizing microneedle arrays to increase skin permeability for transdermal drug delivery","volume":"1161","author":"Al-Qallaf","year":"2009","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.vaccine.2010.06.062_bib41","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/36014","article-title":"Skin immunization made possible by cholera toxin?","volume":"391","author":"Glenn","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2010.06.062_bib42","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1016\/S0264-410X(02)00208-6","article-title":"Comparison of mucosal ans systemic humoral responses after transcutaneous and oral immunization strategies","volume":"20","author":"John","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.06.062_bib43","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S1074-7613(03)00239-5","article-title":"Epicutaneous immunization with autoantigenic peptides induces T suppressor cells that prevent experimental allergic encephalomyelitis","volume":"19","author":"Bynoe","year":"2003","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2010.06.062_bib44","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.4049\/jimmunol.175.3.1373","article-title":"Human dendritic cells: potent antigen-presenting cells at the crossroads of innate and adaptive immunity","volume":"175","author":"Rossi","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2010.06.062_bib45","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1084\/jem.20071724","article-title":"The dermis contains langerin+dendritic cells that develop and function independently of epidermal Langerhans cells","volume":"204","author":"Poulin","year":"2007","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2010.06.062_bib46","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1084\/jem.20071733","article-title":"Blood-derived dermal langerin+dendritic cells survey the skin in the steady state","volume":"204","author":"Ginhoux","year":"2007","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2010.06.062_bib47","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.immuni.2006.01.005","article-title":"Dendritic cells rapidly recruited into epithelial tissues via CCR6\/CCL20 are responsible for CD8+ T cell crosspriming in vivo","volume":"24","author":"Le Borgne","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2010.06.062_bib48","doi-asserted-by":"crossref","first-page":"6324","DOI":"10.1016\/j.vaccine.2007.05.046","article-title":"Echographic measurement of skin thickness in adults by high frequency ultrasound to assess the appropriate microneedle length for intradermal delivery of vaccines","volume":"25","author":"Laurent","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.06.062_bib49","first-page":"163","article-title":"Kinetic expression of endothelial adhesion molecules and relationship to leukocyte recruitment in two cutaneous models of inflammation. Laboratory Investigation","volume":"70","author":"Silber","year":"1994","journal-title":"J Tech Methods Pathol"},{"key":"10.1016\/j.vaccine.2010.06.062_bib50","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.immuni.2005.04.004","article-title":"Dynamics and function of Langerhans cells in vivo: dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells","volume":"22","author":"Kissenpfennig","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2010.06.062_bib51","doi-asserted-by":"crossref","first-page":"61","DOI":"10.4161\/hv.1.2.1554","article-title":"Immunogenicity and tolerability of intradermal administration of an HCV E1-based vaccine candidate in healthy volunteers and patients with resolved or ongoing chronic HCV infection","volume":"1","author":"Leroux-Roels","year":"2005","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.vaccine.2010.06.062_bib52","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.vaccine.2008.10.077","article-title":"Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults","volume":"27","author":"Van Damme","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.06.062_bib53","unstructured":"WHO Technical Report Series, No. 931. Available at: http:\/\/whqlibdoc.who.int\/trs\/WHO8TRS8931_eng.pdf."},{"key":"10.1016\/j.vaccine.2010.06.062_bib54","unstructured":"WHO Report: Intradermal delivery of vaccines, WHO-PATH; 2009."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10008844?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10008844?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T07:43:43Z","timestamp":1740210223000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X10008844"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":54,"journal-issue":{"issue":"36","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S0264410X10008844"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2010.06.062","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.5934958.5932056","asserted-by":"object"}]},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]}}}